Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

China flag China · Delayed Price · Currency is CNY
8.99
-0.14 (-1.53%)
Jun 11, 2026, 2:14 PM CST
Market Cap3.79B +32.3%
Revenue (ttm)288.53M +71.6%
Net Income32.53M
EPS0.09
Shares Out 414.69M
PE Ratio106.93
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,765,600
Open8.86
Previous Close9.13
Day's Range8.75 - 9.18
52-Week Range6.36 - 12.43
Beta0.47
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About SHE:002693

Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical injections, solid preparations, and raw materials in China and internationally. The company offers products for oncology and immune, alimentary canal, heart and cerebral, and vessels and metabolism. It also provides Bivalirudin, Epitifibatide, and Thymalfaxin for injection; Pregabalin capsule; and Memantine Hydrochloride tablets and Pioglitazone tablets USP. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and... [Read more]

Sector Healthcare
Founded 2000
Employees 448
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002693
Full Company Profile

Financial Performance

Financial Statements